Company intelligence / Profile preview

Nathura S.p.A.

Ownership: Private
Development stage: Commercial

Overview

Nathura S.p.A. has established itself as a market leader in Italy for food supplements and medical devices targeting bowel well-being, sleep disorders, and women’s health. Its products are commercially available in Italy and being introduced to international markets. The company was acquired by Giuliani S.p.A. No clinical trial data typical of pharmaceutical development was found; the company operates primarily in consumer healthcare with over-the-counter products.

Therapeutic areas: GastroenterologyDermatologyNeurologyWomen's Health
Modalities: Food supplementsmedical devices (not traditional drug modalities like small molecules or mAbs)
Industry: Food & Nutrition

Drug pipeline

4 assets

Psyllogel

Commercial

Indications: Constipation, Diarrhea

3 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Nathura S.p.A..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nathura S.p.A..

Explore the full profile